HomeBUSINESS
BUSINESS

New IITs for Oncolytic Virus to Begin for Head and Neck Cancer, Sarcoma: Oncolys
(Feb.13.2018)

Oncolys BioPharma President Yasuo Urata
Japanese biotech Oncolys BioPharma said on February 9 that new investigator initiated trials (IITs) are being planned for its oncolytic virus telomelysin (OBP-301) in Japan for the treatment of head and neck squamous cell carcinoma (HNSCC) and sarcoma ...
(LOG IN FOR FULL STORY)

News Calendar